Dual-Sourcing Critical Pharmaceutical Inputs

The challenge

A pharmaceutical manufacturer relied on a single qualified supplier for an active ingredient and a specialised excipient used across important products. Any interruption at that supplier would have affected patients as well as revenue, yet adding a second source meant navigating demanding quality and regulatory requirements.

The approach

A cross-functional team drawn from procurement, quality, regulatory affairs and manufacturing ran the programme together from the start. Candidate suppliers were screened on quality systems, inspection history and technical capability before commercial terms were explored.

Qualification followed the organisation's established change-control process: audits, material comparability testing, trial batches and the regulatory submissions required for each market. Commercial agreements were structured so that the second source received enough volume to remain viable and ready, without undermining the relationship with the incumbent supplier.

What changed

The manufacturer gained a qualified second source for both inputs without any compromise to product quality or compliance. Supply planning gained options it had not had before, and the qualification playbook the team developed became a template for other critical materials.

Lessons for practitioners

In regulated industries, the timeline for dual-sourcing is set by quality and regulatory work, so procurement should involve those colleagues before approaching suppliers rather than after. A second source only improves resilience if it is kept active enough to be relied upon.